arrow
D

Diego de Miguel-Pérez

ica hn school of medicine at mount sinai
H指数:23
被引数:1,869

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Hernández-Pedro et al. Impact of Tyrosine Kinase Inhibitors on the Immune Response to SARS-CoV-2 Vaccination in Patients with Thoracic Malignancies. Vaccines 2023, 11, 1612

更正:Hernández-Pedro等人. 酪氨酸激酶抑制剂对胸癌患者SARS-CoV-2疫苗接种免疫反应的影响. Vaccines 2023, 11, 1612

2025-08-280
OA
Extracellular vesicles containing SARS-CoV-2 proteins are associated with multi-organ dysfunction and worse outcomes in patients with severe COVID-19
2024-11-190
OA
Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors

揭示循环肿瘤细胞的影响: 实体瘤的二十年发现和临床进展

2024-11-010
PRE
Resectable Non-Small Cell Lung Cancer Heterogeneity and Recurrence Assessed by Tissue Next-Generation Sequencing Genotyping and Circulating Tumor Cell EZH2 Characterization

可切除非小细胞肺癌异质性及复发评估:基于组织下一代测序基因分型和循环肿瘤细胞EZH2特征分析

2024-10-010
PRE
Genomic profiling of tissue and blood predicts survival outcomes in patients with resected pleural mesothelioma
2024-01-010
PRE
Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort Study
2023-04-0512
OAAI
Combined extracellular vesicle PD-L1 and radiomics as predictors of response in patients with advanced lung cancer undergoing immunotherapy
2023-04-040
PRE
Baseline extracellular vesicle TGF-β is a predictive biomarker for response to immune-checkpoint inhibitors and survival in non-small-cell lung cancer
CANCER
IF5.1
2022-12-0925
PRE
Mechanisms of Resistance to First-Line Osimertinib in Hispanic Patients With EGFR Mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP)

EGFR突变型非小细胞肺癌 (freston-clicap) 患者一线奥希替尼耐药机制的研究

2022-09-019
PRE